Disclosure of payments made to HCPs and HCOs in the UK

Disclosure of payments made to HCPs and HCOs in the UK

ALK-Abelló Ltd is committed to greater transparency of financial relationships with healthcare professionals and healthcare organisations. Alongside other ABPI member companies, from 2015 we are disclosing all transfers of value made to individually named healthcare professionals and healthcare organisations. This is in line with the ABPI Code of Practice as well as the EFPIA Disclosure Code, which has been adopted across 33 European countries.

Our payments made to HCPs and HCOs in the UK in 2018

Our 2018 transfers of value to individual Health Care Professionals (HCPs) and Health Care Organisations (HCOs) have been submitted to the ABPI disclosure database and will be available on their platform from 28th June 2019.

In 2018 ALK-Abelló Ltd paid a total of £37,875.86 to support 61 UK HCP’s to attend scientific conferences and meetings, to speak at ALK-Abelló meetings and to provide various consultancy services. Details of individual payments can be found on the ABPI platform. Disclosure at an individual level is voluntary. Where consent has not been obtained to disclose on a named basis the total amount is shown in aggregate.

Additionally ALK-Abelló Ltd paid a total of £48,230.42 to HCO’s. Details of individual payments to HCO’s can be found on the ABPI platform. Please follow this link to the ABPI disclosure platform for full details: www.disclosureuk.org.uk

Financial Support Given to Patient Organisations

In 2018 ALK UK Ltd gave financial support to the following patient organisations & charities:

Anaphylaxis Campaign £30,073.50

Educational support to help raise awareness of the signs, symptoms and treatment options for patients at risk of anaphylaxis.

British Beekeepers Association £6,000

Educational support to help raise awareness of the signs, symptoms and treatment options for patients at risk of anaphylaxis.

Allergy UK £3,250

Educational support to help raise awareness of the signs, symptoms and treatment options for patients at risk of anaphylaxis.

Last updated: 2019.08.01